Maana recently won GCV’s inaugural award for energy-tech corporate venture capital (CVC) investment of the year, presented during its Venture Houston conference in November. Now, Maana has gone one-stage further and won the Sub-$50m Investment of the Year award across all industries.
SoftBank Vision Fund led a series B round for the cancer therapy developer that was also backed by GV and Alexandria Venture Investments.
The molecular product technology provider followed a nine-figure, SoftBank-led round two years ago with a series C led by the corporate's Vision Fund.
The GV-backed financial software technology provider raised series C funding in a Kleiner Perkins-led round that valued it at $2.65bn.